Compare
5 stocks, side by sideRelative performance · rebased to 100
CRNXTLXNAMSRCUSELVN
| CRNXCrinetics Pharmaceuticals, Inc. | TLXTelix Pharmaceuticals Limited | NAMSNewAmsterdam Pharma Company N.V. | RCUSArcus Biosciences, Inc. | ELVNEnliven Therapeutics, Inc. | |
|---|---|---|---|---|---|
| Smart Score | 9/10 | - | 3/10 | 6/10 | 9/10 |
| Price | $84.96 | $12.00 | $25.66 | $29.02 | $59.35 |
| 1 month | +1.3% | +13% | -7.1% | +2.2% | -1.6% |
| 1 year | +210% | +0.84% | +1.0% | +177% | +200% |
| 5 year | +384% | - | +165% | +5.8% | +208% |
| P/E (TTM) | -16.5 | - | -14.4 | -9.2 | -36.2 |
| P/E vs sector | - | - | - | - | - |
| Market cap | $3.7B | $3.7B | $3.7B | $3.8B | $3.5B |
| Sector | Healthcare | Healthcare | Healthcare | Healthcare | Healthcare |
Risk / Return · past yearAnnualized return vs volatility, up-and-left is more reward for less risk.
Correlation · do they move together?Pairwise daily-return correlation over the past year, high = one bet, low = diversifying.